Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia

ES LittlejohnDepartment of General Medicine; Royal Children's Hospital; Melbourne, AustraliaCorrespondence[email protected]

HJ ClothierSurveillance of Adverse Events Following Immunization in Victoria (SAEFVIC); Murdoch Children's Research Institute; Melbourne, Australia;School of Population and Global Health; The University of Melbourne; Melbourne, Australia

KP PerrettDepartment of General Medicine; Royal Children's Hospital; Melbourne, Australia;Surveillance of Adverse Events Following Immunization in Victoria (SAEFVIC); Murdoch Children's Research Institute; Melbourne, Australia;Vaccine and Immunization Research Group (VIRGo); Murdoch Children's Research Institute and School of Population and Global Health; The University of Melbourne; Melbourne, Australia

M DanchinDepartment of General Medicine; Royal Children's Hospital; Melbourne, Australia;Surveillance of Adverse Events Following Immunization in Victoria (SAEFVIC); Murdoch Children's Research Institute; Melbourne, Australia;Vaccine and Immunization Research Group (VIRGo); Murdoch Children's Research Institute and School of Population and Global Health; The University of Melbourne; Melbourne, Australia

Figures & data

Table 1. Concomitant vaccines given with the primary series or catch up pneumococcal vaccines in the Victorian Immunization schedule,Citation⁸ over the study period

Download CSV Display Table

Table 2. AEFI reported frequencies and rates per 100,000 doses administered for each cohort and comparison data

Download CSV Display Table

Table 3. Characteristics of the four study cohorts

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia

Table 1. Concomitant vaccines given with the primary series or catch up pneumococcal vaccines in the Victorian Immunization schedule,Citation⁸ over the study period

Table 2. AEFI reported frequencies and rates per 100,000 doses administered for each cohort and comparison data

Table 3. Characteristics of the four study cohorts

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia

Figures & data

Table 1. Concomitant vaccines given with the primary series or catch up pneumococcal vaccines in the Victorian Immunization schedule,Citation8 over the study period

Table 2. AEFI reported frequencies and rates per 100,000 doses administered for each cohort and comparison data

Table 3. Characteristics of the four study cohorts

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 1. Concomitant vaccines given with the primary series or catch up pneumococcal vaccines in the Victorian Immunization schedule,Citation⁸ over the study period